BioMason has no published valuation. The company is private, so there is no listed share price.
The routes section explains what is realistically available for a company at this stage.
No. BioMason is a private company; its shares do not trade on a public exchange.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
